KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 110 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $211,000 | -42.0% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $364,000 | +2.5% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $355,000 | -35.1% | 36,200 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $547,000 | +6.2% | 36,200 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $515,000 | +219.9% | 36,200 | +120.7% | 0.00% | +100.0% |
| Q3 2019 | $161,000 | -19.9% | 16,400 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $201,000 | -52.0% | 32,800 | +65.7% | 0.00% | -50.0% |
| Q1 2019 | $419,000 | +175.7% | 19,800 | +20.7% | 0.00% | +100.0% |
| Q4 2018 | $152,000 | -63.7% | 16,400 | -17.2% | 0.00% | -50.0% |
| Q3 2018 | $419,000 | +21.8% | 19,800 | -2.5% | 0.00% | 0.0% |
| Q2 2018 | $344,000 | +27.9% | 20,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $269,000 | +100.7% | 20,300 | +31.0% | 0.00% | 0.0% |
| Q1 2016 | $134,000 | -44.9% | 15,500 | -14.8% | 0.00% | -33.3% |
| Q4 2015 | $243,000 | +27.9% | 18,200 | +1.1% | 0.00% | +50.0% |
| Q3 2015 | $190,000 | -59.7% | 18,000 | +4.0% | 0.00% | -66.7% |
| Q2 2015 | $471,000 | -7.8% | 17,300 | +3.6% | 0.01% | 0.0% |
| Q1 2015 | $511,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |